{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:05:22Z","timestamp":1793289922025,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ajog.2017.11.561","type":"journal-article","created":{"date-parts":[[2017,11,12]],"date-time":"2017-11-12T08:15:41Z","timestamp":1510474541000},"page":"287-293.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":566,"title":["Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis"],"prefix":"10.1016","volume":"218","author":[{"given":"Stephanie","family":"Roberge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Bujold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kypros H.","family":"Nicolaides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2017.11.561_bib1","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0140-6736(10)60279-6","article-title":"Pre-eclampsia","volume":"376","author":"Steegers","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2017.11.561_bib2","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/uog.12421","article-title":"Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis","volume":"41","author":"Roberge","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.11.561_bib3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ajog.2016.10.016","article-title":"Antiplatelet therapy before or after 16 weeks\u2019 gestation for preventing preeclampsia: an individual participant data meta-analysis","volume":"216","author":"Meher","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.11.561_bib4","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajog.2016.09.076","article-title":"The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis","volume":"216","author":"Roberge","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.11.561_bib5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000336662","article-title":"Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis","volume":"31","author":"Roberge","year":"2012","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.ajog.2017.11.561_bib6","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/AOG.0b013e3181e9322a","article-title":"Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis","volume":"116","author":"Bujold","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.11.561_bib7","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk of preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2017.11.561_bib8","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S0140-6736(85)92207-X","article-title":"Prevention of pre-eclampsia by early antiplatelet therapy","volume":"1","author":"Beaufils","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2017.11.561_bib9","first-page":"1122","article-title":"Hypertension in pregnancy: Report of the American College of Obstetricians and Gynecologists\u2019 Task Force on Hypertension in Pregnancy","volume":"122","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.11.561_bib10","doi-asserted-by":"crossref","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.ajog.2017.11.561_bib11","unstructured":"Cochrane Handbook for Systematic Reviews of Interventions In: Higgins J, Green S, eds: The Cochrane Collaboration; 2011. Available at: http:\/\/handbook.cochrane.org. Accessed July 26, 2017."},{"key":"10.1016\/j.ajog.2017.11.561_bib12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-Analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.ajog.2017.11.561_bib13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2288-7-5","article-title":"Inclusion of zero total event trials in meta-analyses maintains analytic consistency and incorporates all available data","volume":"7","author":"Friedrich","year":"2007","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.ajog.2017.11.561_bib14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1258\/1355819021927674","article-title":"Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice","volume":"7","author":"Higgins","year":"2002","journal-title":"J\u00a0Health Serv Res Policy"},{"key":"10.1016\/j.ajog.2017.11.561_bib15","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"Br Med J"},{"key":"10.1016\/j.ajog.2017.11.561_bib16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1471-0528.1998.tb10089.x","article-title":"A\u00a0randomised trial of low dose aspirin for primiparae in pregnancy. The Jamaica low dose aspirin study group","volume":"105","author":"Golding","year":"1998","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2017.11.561_bib17","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJM199803123381101","article-title":"Low-dose aspirin to prevent preeclampsia in women at high risk: National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units","volume":"338","author":"Caritis","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2017.11.561_bib18","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1056\/NEJM199310213291701","article-title":"Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women: The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units","volume":"329","author":"Sibai","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2017.11.561_bib19","first-page":"355","article-title":"Low-dose aspirin prescribed at bed time for the prevention of pre-eclampsia in high-risk pregnant women","volume":"32","author":"Zhao","year":"2012","journal-title":"Reprod Contracept"},{"key":"10.1016\/j.ajog.2017.11.561_bib20","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/uog.218","article-title":"Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks\u2019 gestation","volume":"22","author":"Yu","year":"2003","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.11.561_bib21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1471-0528.1996.tb09513.x","article-title":"ECPPA: randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women: ECPPA (Estudo Colaborativo para Prevencao da Pre-eclampsia com Aspirina) Collaborative Group","volume":"103","year":"1996","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2017.11.561_bib22","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1471-0528.2003.t01-1-02097.x","article-title":"Aspirin (100 mg) used for prevention of pre-eclampsia in nulliparous women: the Essai Regional Aspirine Mere-Enfant study (Part 1)","volume":"110","author":"Subtil","year":"2003","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2017.11.561_bib23","first-page":"161","article-title":"Low dose acetylsalicylic acid in prevention of pregnancy-induced hypertension and intrauterine growth retardation in women with bilateral uterine artery notches","volume":"109","author":"Vainio","year":"2002","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2017.11.561_bib24","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/hr.2011.111","article-title":"Prevention of gravidic endothelial hypertension by aspirin treatment administered from the 8th week of gestation","volume":"34","author":"Bakhti","year":"2011","journal-title":"Hypertens Res"},{"key":"10.1016\/j.ajog.2017.11.561_bib25","article-title":"Low dose aspirin for preventing fetal growth restriction: a randomised trial","volume":"43","author":"Stanescu","year":"2015","journal-title":"J\u00a0Perinat Med"},{"key":"10.1016\/j.ajog.2017.11.561_bib26","unstructured":"August P, Helseth G, Edersheim T, Hutson J, Druzin M. Sustained release, low-dose aspirin ameliorates but does not prevent preeclampsia (PE) in a high risk population. Paper presented at: Proceedings of 9th International Congress, International Society for the Study of Hypertension; 1994 March 15-18, 1994; Sydney, Australia."},{"key":"10.1016\/j.ajog.2017.11.561_bib27","first-page":"826","article-title":"Usefulness of aspirin therapy in high-risk pregnant women with abnormal uterine artery Doppler ultrasound at 14-16 weeks pregnancy: randomized controlled clinical trial","volume":"46","author":"Ebrashy","year":"2005","journal-title":"Croat Med J"},{"key":"10.1016\/j.ajog.2017.11.561_bib28","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/uog.14889","article-title":"Early prediction and aspirin for prevention of pre-eclampsia (EPAPP) study: a randomized controlled trial","volume":"46","author":"Odibo","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.11.561_bib29","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/uog.17351","article-title":"Impact of aspirin on trophoblastic invasion in women with abnormal uterine artery Doppler at 11-14 weeks: a randomized controlled study","volume":"49","author":"Scazzocchio","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.11.561_bib30","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1471-0528.2012.03493.x","article-title":"Aspirin in the prevention of pre-eclampsia in high-risk women: a randomised placebo-controlled PREDO Trial and a meta-analysis of randomised trials","volume":"120","author":"Villa","year":"2013","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2017.11.561_bib31","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/uog.12470","article-title":"Aspirin for pre-eclampsia: beware of subgroup meta-analysis","volume":"41","author":"Meher","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.11.561_bib32","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1056\/NEJM199708213370806","article-title":"Discrepancies between meta-analyses and subsequent large randomized, controlled trials","volume":"337","author":"LeLorier","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2017.11.561_bib33","doi-asserted-by":"crossref","unstructured":"Wright D, Poon LC, Rolnik DL, et\u00a0al. Aspirin for Evidence-Based Preeclampsia Prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia. Am J Obstet Gynecol 2017. [Epub ahead of print.] https:\/\/doi:10.1016\/j.ajog.2017.08.110.","DOI":"10.1016\/j.ajog.2017.08.110"},{"key":"10.1016\/j.ajog.2017.11.561_bib34","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","article-title":"Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data","volume":"369","author":"Askie","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2017.11.561_bib35","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/hr.2011.214","article-title":"Prevention of gravidic endothelial hypertension by aspirin treatment administered from the 8th week of gestation","volume":"35","author":"Bakhti","year":"2012","journal-title":"Hypertens Res"},{"key":"10.1016\/j.ajog.2017.11.561_bib36","unstructured":"American College of Obstetricians and Gynecologists. Task Force on Hypertension in Pregnancy; Hypertension, Pregnancy-Induced-Practice Guideline, American College of Obstetrician and Gynecologist. Washington (DC): Library of congress; 2013:WQ\u00a0244."},{"key":"10.1016\/j.ajog.2017.11.561_bib37","unstructured":"NICE Clinical Guideline. National Collaborating Centre for Women\u2019s and Children\u2019s Health. Commissioned by the National Institute for Health and Clinical Excellence. Hypertension in pregnancy: The management of hypertensive disorders during pregnancy. CG107. Available at: http:\/\/guidance.nice.org.uk\/CG107. 2012. Accessed August 8, 2017."},{"key":"10.1016\/j.ajog.2017.11.561_bib38","doi-asserted-by":"crossref","first-page":"141.e1","DOI":"10.1016\/j.ajog.2016.09.086","article-title":"Should we recommend universal aspirin for all pregnant women?","volume":"216","author":"Mone","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.11.561_bib39","doi-asserted-by":"crossref","first-page":"62.e1","DOI":"10.1016\/j.ajog.2015.02.018","article-title":"Competing risks model in screening for preeclampsia by maternal characteristics and medical history","volume":"213","author":"Wright","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.11.561_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2015.08.034","article-title":"Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation","volume":"214","author":"O\u2019Gorman","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.11.561_bib41","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/uog.17455","article-title":"Multicenter screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks\u2019 gestation: comparison to NICE guidelines and ACOG recommendations","volume":"49","author":"O\u2019Gorman","year":"2017","journal-title":"Ultrasound Obstet Gynecol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937817323268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937817323268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:18:05Z","timestamp":1757589485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937817323268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0002937817323268"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2017.11.561","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732119367.793579070","asserted-by":"object"}]},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2017.11.561","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}